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ABSTRACT: Apolipoprotein E4 (ApoE4) is the main genetic risk factor
for Alzheimer’s disease (AD), but the exact way in which it causes AD
remains unclear. Curcumin is considered to have good therapeutic potential
for AD, but its mechanism has not been clarified. This study aims to observe
the effect of curcumin on ApoE4 transgenic mice and explore its possible
molecular mechanism. Eight-month-old ApoE4 transgenic mice were
intraperitoneally injected with curcumin for 3 weeks, and the Morris
water maze test was used to evaluate the cognitive ability of the mice.
Immunofluorescence staining, immunohistochemistry, western blotting, and
enzyme-linked immunosorbent assay (ELISA) were used to examine the
brain tissues of the mice. Curcumin reduced the high expression of ApoE4
and the excessive release of inflammatory factors in ApoE4 mice. In
particular, the expression of marker proteins of endoplasmic reticulum (ER)
stress was significantly increased in ApoE4 mice, while curcumin significantly reduced the increase in the expression of these
proteins. Collectively, curcumin alleviates neuroinflammation in the brains of ApoE4 mice by inhibiting ER stress, thus improving
the learning and cognitive ability of transgenic mice.
1. INTRODUCTION
Alzheimer’s disease (AD) is a neurological disease charac-
terized by profound memory loss and progressive dementia
and is the most common cause of dementia in the elderly.
More than 50 million patients worldwide are affected by AD,
and this number is expected to quadruple by 2050. Alzheimer’s
disease is a serious and unresolved economic and public health
problem, and there is an urgent need to develop effective
treatments to prevent its development.1,2
In addition to amyloid plaques (APs) formed by β-amyloid
peptides (Aβ) and neurofibrillary tangles (NFTs) caused by
Tau protein phosphorylation,3 neuroinflammation, and neuro-
nal degeneration are the main features of AD.4,5 Although the
main causes of neuronal death in AD are generally believed to
be APs and NFTs, it is clear that other biological response
modulators, including local chronic inflammatory responses
mediated by glial cells, also have an impact on the pathological
process.6
Apolipoprotein E (ApoE), a 299-amino-acid protein with a
molecular weight of 34 kDa, plays an important role in lipid
and cholesterol transport and lipoprotein metabolism in the
central and peripheral nervous systems. ApoE has three alleles,
ε2, ε3, and ε4. Among them, the ε4 allele (ApoE4) is the main
genetic risk factor for AD,7 which has been recognized for
decades; however, the role of ApoE4 in the pathogenesis of AD
has not yet been elucidated. In recent years, ApoE4 has been
found to be a major genetic risk factor for a variety of
inflammatory diseases, including atherosclerosis, diabetes, and
Alzheimer’s disease.8−11
Sustained endoplasmic reticulum (ER) stress is considered a
pathological driver of many chronic diseases because it may
cause abnormal inflammatory signals and promote cell death.12
In neurodegenerative disease, the accumulation of misfolded
proteins in neurons and associated ER stress can lead to
neuronal dysfunction.13 In addition, ER stress may promote
disease progression by enhancing the destructive inflammatory
response. However, the specific mechanism of ER stress-
mediated neuroinflammation is still unknown.14
Curcumin (molecular structure is shown in Figure S1) is a
polyphenolic substance extracted from turmeric, a plant of the
curcuma family.15 Toxicity studies have shown that it is quite
safe even at high doses (up to 12 g in humans).16 Curcumin’s
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pharmacological action is exerted at multiple sites, including
enzymes, transcription factors, growth factors, neurotransmit-
ter receptors, inflammatory mediators, and a large number of
protein kinases. It has anti-inflammatory, antitumor, antiox-
idative, and antibacterial effects.17 Curcumin has been used as
a condiment in food in Southeast Asia for centuries.18
Figure 1. ApoE4 expression is enhanced in transgenic mice. (A) Localization of ApoE4 in the brains of each group of mice. Scale bar = 20 μm. (B)
Quantification based on the average positive area. Data are expressed as the mean ± standard error of the mean (SEM) n = 3. *p < 0.05 versus WT-
Con; #p < 0.05 versus ApoE4-Tg.
Figure 2. Curcumin ameliorated learning and memory impairment in ApoE4-Tg mice. The training trials were performed three times a day for 4
days. The swimming distance and swimming time before arrival at the platform were automatically recorded. Twenty-four hours after the training
trials, a probe test was performed. (A) Time to reach the hidden platform. (B) Total swimming distance during the trial. (C) Tracks of the mice in
the probe trial on the fifth day. (D) Number of times the mice crossed over the platform location in the probe trial. (E) Duration of time spent in
the target zone area in the probe trial. All values are presented as the mean ± SEM n = 6. *p < 0.01 versus WT-Con; #p < 0.05 versus ApoE4-Tg.
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According to the initial epidemiological analysis of the Indian
population, curcumin has a strong potential to treat AD.19 The
incidence of AD was 4.4-fold lower in long-term curcumin
users than those without curcumin in the United States, but
whether curcumin affected ER stress in AD remains unclear.20
In this study, ApoE4 transgenic mice were used as model
animals of AD to observe the effect of curcumin and to
investigate whether curcumin can inhibit neuroinflammation in
ApoE4 transgenic mice by inhibiting ER stress, thereby
improving the cognitive ability of the model mice.
2. RESULTS
2.1. Curcumin Reduced the High Expression of
ApoE4 in Transgenic Mice. Immunofluorescence staining
showed that the expression of ApoE4 was enhanced in the
brains of transgenic mice, while curcumin reduced the high
expression of ApoE4 in the brains of transgenic mice to a level
similar to those of wild-type (WT) control mice (Figure 1).
2.2. Curcumin Reduced Spatial Learning Deficits in
ApoE4-Tg Mice. The Morris water maze test is a widely
accepted method to examine cognitive function, and it was
used to evaluate the spatial learning and memory abilities of
mice in this study. All mice were trained for 4 days and tested
three times a day. In the training phase, each group showed an
effect on learning. Compared with those in the WT-Con group
and the WT + Cur group, mice in the ApoE4-Tg group
required a longer time and distance to reach the platform,
while those in the ApoE4 + Cur group showed a shorter
incubation period and escape distance, which was significantly
different from those of the transgenic mice group (Figure
2A,B).
After the water maze test, we conducted a probe test to
investigate memory retention. In the probe test, the time spent
in the platform area and the number of times that the mice
crossed the platform were all significantly reduced in ApoE4-
Tg mice compared to those in the WT-control group, which
could be restored in ApoE4-Tg mice after curcumin treatment
(ApoE4 + Cur) (Figure 2C−E).
2.3. Curcumin Reduced Neuronal Cell Death in
ApoE4-Tg Mice. The survival rate of neurons was determined
by crystal violet staining. In the WT-control group and the WT
+ cur group, neurons in the hippocampal and cortical regions
exerted good morphology and were closely arranged; in
contrast, neurons in the ApoE4-Tg group were not well
defined. Moreover, compared with those in the WT-control
group, the number of neurons in the ApoE4-Tg group was
significantly reduced, while the cell morphology and the
number of neurons in the ApoE4 + cur group were improved
and significantly increased, respectively (Figure 3).
2.4. Curcumin Alleviated Cerebral Inflammation in
ApoE4-Tg Mice. To determine the neuroinflammatory
response in ApoE4 mice, we detected the expression of
COX-2 and iNOS by immunofluorescence staining and the
levels of TNF-α and IL-1β by ELISA. The immunofluor-
escence results showed that the expressions of COX-2 and
iNOS in the brains of ApoE4-Tg mice were significantly higher
than those in the brains of WT mice, and curcumin treatment
significantly inhibited COX-2 and iNOS expressions in ApoE4-
Tg mice (Figure 4A,B). Our results also showed that the levels
of TNF-α and IL-1β in the brains of ApoE-Tg mice were
significantly higher than those in the brains of WT mice, which
could be reduced by the treatment of curcumin in ApoE4-Tg
mice (Figure 4C,D).
2.5. Curcumin Inhibited the Activation of NF-κB in
ApoE4-Tg Mice. NF-κB is a critical transcription factor that
regulates the inflammatory response, so we examined the
activation of NF-κB in ApoE4-Tg mice. The western blotting
results showed that the translocation of the NF-κB subunit p65
to the nucleus was obviously enhanced in ApoE4-Tg mice
compared with that in WT mice, while curcumin inhibited the
nuclear translocation of p65 in ApoE4 mice (Figure 5).
2.6. Curcumin Inhibited Endoplasmic Reticulum (ER)
Stress in ApoE4-Tg Mice. We detected the expression of the
marker proteins of ER stress in mice by immunohistochem-
istry. The results showed that positive staining of GRP78 or
IRE1α cells in ApoE4-Tg mice was increased significantly,
Figure 3. Curcumin alleviated the pathological changes in neuronal cells in ApoE4-Tg mice. Nissl staining of the neuronal cells. Representative
images were chosen from each experimental group. Scale bar = 20 μm.
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suggesting that ER stress occurred in ApoE4-Tg mice.
However, the curcumin treatment significantly reduced the
number of GRP78-positive and IRE1α-positive cells in
transgenic mice (Figure 6A).
Next, the expressions of GRP78 and IRE1α proteins were
determined by western blotting. Consistent with the
immunohistochemical results, their expressions in ApoE4-Tg
mice were significantly higher than those in wild-type mice,
while curcumin treatment inhibited the increase in the
expression of these two proteins (Figure 6B).
3. DISCUSSION
ApoE4 is the most important genetic risk factor for sporadic
AD.21 Individuals with one or two ApoE4 alleles have a 4−8-
fold increased risk of AD, and the onset age of AD is 7−15
years earlier for these individuals. Studies have shown that the
brain physiology of ApoE4 carriers changes years before
clinical markers, such as Aβ and tau pathology and memory
deficits, appear.22 Similarly, mice expressing human ApoE4
showed signs of impaired learning and memory, neuro-
degeneration,23 and increased amyloid-β (Aβ) peptide
accumulation and subsequent deposition in the brain.24
Besides, studies of Lewandowski et al.25 and Shi et al.26
strongly suggested ApoE4 transgenic mice as model animals
for Alzheimer’s disease. In our study, compared with those of
the wild-type mice, the learning and memory abilities of the
ApoE4 transgenic (ApoE4-Tg) mice were significantly
decreased, and the dramatic loss of neurons in the brain of
this model confers the link between ApoE4 and AD.
Studies have shown that ApoE4 is a major genetic risk factor
for atherosclerosis, vascular dementia,27 diabetes,28 and other
diseases that are closely related to inflammation. Therefore, the
relationship between ApoE4 and inflammation has drawn
increasing attention. Pathological changes caused by neuro-
inflammation occur in the brains of patients with AD,29 and it
has been recognized that abnormal inflammatory processes in
the central nervous system (CNS) can lead to neurological
dysfunction;30 neuroinflammation plays an important role in
the degeneration of AD neurons and is involved in the vicious
cycle of Aβ deposition, neuron damage, tangle formation, and
death.31 The results of this study showed that the release of
inflammatory cytokines in the brains of ApoE4 mice was
significantly increased compared with that in the brains of
wild-type mice, suggesting that ApoE4 is closely related to
neuroinflammation in the central nervous system.
ER stress results in a protective cellular stress response by
activating the unfolded protein response (UPR) and other
signaling pathways in response to various damaging con-
ditions.32,33 However, under the conditions of continuous ER
Figure 4. Effects of curcumin on the release of proinflammatory
cytokines in ApoE4-Tg mice. Expressions of COX-2 (A) and iNOS
(B) in mice are determined by immunofluorescence staining.
Representative images of stained tissues are captured using a
microscope. Scale bar = 20 μm. Levels of TNF-α (C) and IL-1β
(D) are detected by ELISA. Data are expressed as the mean ± SEM n
= 3. * *p < 0.01 versus WT-Con; #p < 0.05 versus ApoE4-Tg.
Figure 5. Effects of curcumin on NF-κB activity in ApoE4-Tg mice. (A) Expression of p65 in the total and nuclear fractions is determined by
western blotting analysis. (B) Protein expression is normalized to that of β-actin or lamin B, and the relative densities were normalized to those of
the WT mice. The values presented are the mean ± SEM n = 3. ##p < 0.01 versus WT-Con; **p < 0.01 versus ApoE4-Tg.
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stress, cells will reduce self-protection and initiate cell death
signaling. It has been reported that ER stress induces Aβ to
contribute to neurodegeneration in AD.34 In addition, several
reports have described the activation of the ER stress response
in AD mouse models. Normally, glucose-regulated protein 78
(GRP78) binds to inositol-requiring enzyme 1α (IRE1α),35
protein kinase-like endoplasmic reticulum kinase (PERK), and
activated transcription factor 6 (ATF6) to form a complex and
remains inactive. When ER stress is induced by injury, GRP78
dissociates from PERK, IRE1α, and ATF6 to initiate the
UPR.36 Therefore, GRP78 is regarded as an important marker
for ER stress. In our study, expression of GRP78 was higher in
ApoE4-Tg mice than in wild-type mice, confirming the
activation of ER stress in ApoE4-Tg mice. In mammalian
cells, the mediators involved in triggering the UPR response
are IRE1α, PERK, and ATF6,37,38 each of which activates a
different signaling pathway to produce the corresponding
effect.39 During the ER stress response, after oligomerization,
IRE1α recruits the adapter protein tumor necrosis factor-α
receptor-associated factor 2 (TRAF2), and the formation of
the IRE1α−TRAF2 complex mediates the activation of NF-κB
signaling pathways.40−45 NF-κB is a transcription factor that
initiates and regulates the expression of several inflammatory
processes that are attributed to the pathology of several
neurodegenerative diseases. When the NF-κB signaling path-
way was activated, it would cause the increase of inflammatory
factors, such as IL-6, TNF-α, etc.46 Therefore, there seems to
be an interesting relationship between ER stress and
neuroinflammation. In our study, compared with wild-type
mice, the expressions of inflammatory cytokines in the brain of
ApoE4-Tg mice were increased dramatically. In addition, our
results also showed that the NF-κB signaling pathway was
activated in the brains of ApoE4-Tg mice, accompanied by a
higher expression of IRE1α compared to wild-type control
mice. However, we did not investigate on the ATF6-mediated
pathway in ER stress, and the expression of the IRE1α pathway
downstream player TRAF2 was also not examined. Hence, we
were unable to decipher the effect of curcumin on the precise
network in ER stress, which could be the limitations of our
study.
Curcumin, as an effective anti-inflammatory small molecule,
was shown to inhibit the COX-2 expression in human colon
cancer cells.47 It also alleviated LPS-induced inflammation by
switching a proinflammatory M1 microglial to an anti-
inflammatory M2 phenotype via reducing the imbalance of
TREM2 and TLR4 and balancing the downstream NF-κB
activation.48 Recently, Wang et al.49 have proven that curcumin
can inhibit ApoE4-induced injury by upregulating the
expression of peroxisome proliferator-activated receptor-γ to
inhibit the activation of NF-κB signaling in SH-SY5Y cells.
Apart from the anti-inflammatory role, curcumin also acts as a
known antioxidant that scavenges reactive oxygen species
(ROS). Zheng et al. found that curcumin can protect SH-SY5Y
cells against appoptosin-induced intrinsic caspase-dependent
apoptosis by increasing heme oxygenase-1 expression and
reducing ROS production.50 Chhunchha et al.51 also proposed
that curcumin could reinforce the naturally occurring Prdx6
expression, attenuate ROS-based ER stress and NF-κB-
mediated aberrant signaling, then improve the survival of
mouse hippocampal cells (HT22), and may provide an avenue
to treat and/or postpone diseases associated with ROS or ER
stress. In the findings of Feng et al.,52 they indicated that
curcumin could inhibit the PERK−eIF2α−CHOP axis of the
ER stress response through the activation of SIRT1 in tert-
butyl hydroperoxide (TBHP)-treated rat chondrocytes and
ameliorated osteoarthritis development in vivo. Together, the
previous studies focused either on the anti-inflammatory effect
of curcumin in vitro under various stimuli or on its protection
against ER stress in other inflammatory diseases. Instead, our
study provided the evidence that curcumin alleviated AD
development by reducing inflammatory cytokines and ER
stress in brain tissues from ApoE4-Tg mice.
Taken together, we speculated that ApoE4 induced ER
stress in mice, activated the inflammatory signaling pathway,
led to neuroinflammation in the central nervous system, and
affected the learning and memory ability of animals. In
Figure 6. Expression of ER stress marker proteins in ApoE4-Tg mice. (A) Expressions of GRP78 and IRE1α in WT and ApoE4-Tg mice were
determined by immunohistochemistry. Representative images of stained tissues were captured using a microscope. Scale bar = 20 μm. (B)
Expressions of GRP78 and IRE1α were detected through western blotting using specific antibodies in mouse brain tissues. The values presented are
the means ± SEM n = 3. ##p < 0.01 versus WT-Con; **p < 0.01 versus ApoE4-Tg.
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contrast, curcumin treatment inhibited the occurrence of ER
stress and activation of the NF-κB signaling pathway in ApoE4-
Tg mice, indicative of improved neuroinflammation and finally
leading to better learning and memory ability in ApoE4-Tg
mice (Figure 7).
4. MATERIALS AND METHODS
4.1. Compounds and Reagents. Curcumin (purity
>98.0%) was obtained from Sigma Technology (Danvers).
Nissl staining solution was purchased from Beyotime
Biotechnology Co., Ltd. (Shanghai, China). TNF-α and IL-
1β enzyme-linked immunosorbent assay (ELISA) kits were
provided by Elabscience Biotechnology Co., Ltd. (Wuhan,
China). 4′,6-Diamidino-2-phenylindole (DAPI) was purchased
from Solarbio Science (Beijing, China). The ApoE4, COX-2,
iNOS, NF-κBp65, p-NF-κBp65, GRP78, IRE1α, β-actin, and
IgG primary antibodies and Alexa Fluor 488 fluorescent
secondary antibodies were all purchased from Abcam and were
used at the indicated dilutions for western blotting and
immunostaining.
4.2. Animals. ApoE4 transgenic mice (SCXK2016-0004)
with a C57BL/6 J background and C57BL/6 J mice were
obtained from Jiangsu ALF Biotechnology Co., Ltd. (Nanjing,
China). The C57BL/6 J mice were used as wild-type control
mice. ApoE4 mice were genotyped by PCR amplification of
genomic DNA extracted from tail snips.
Animals were housed in a facility under a 12 h/12 h light/
dark cycle and had access to food and water ad libitum. Male
and female transgenic (Tg) or wild-type (WT) mice aged 8
months were used in all studies. All animal experiments utilized
protocols that were performed according to the Guidelines for
the Care and Use of Laboratory Animals (Ministry of Science
and Technology of the People’s Republic of China) and the
Ethics Committee of Henan University.
4.3. Experimental Design. The mice were divided into
the following four groups, and there were eight mice in each
group, half male and half female: WT-control, ApoE4-Tg,
ApoE4 + curcumin (40 mg/kg), and WT + curcumin (40 mg/
kg). Curcumin was dissolved in <1% dimethyl sulfoxide
(DMSO) and injected intraperitoneally once a day for 3 weeks.
After 3 weeks of continuous administration, the Morris water
maze test was carried out for 4 consecutive days. The probe
test was performed 24 h (i.e. day 5) after the navigation test
(Figure 8). The weight of mice was 25−30 g, and the effect of
curcumin on body weight is shown in the Supporting
Information (Figure S2).
4.4. Morris Water Maze Test. The Morris water maze test
was used to assess spatial learning and memory in this study.
The mice were placed in a circular pool (40 cm high, 120 cm
diameter) for a series of tests at a temperature of 22−25 °C.
The mice were trained to find an escape platform (diameter 8
cm) that was submerged 1− 1.5 cm below the surface of the
water. Each trial lasted 90 s or ended immediately after the
mice reached the underwater platform. If the animal failed to
find the platform within 90 s, it was guided to the platform and
allowed to stay there for 15−20 s. Each animal had three
random starting points, and the test was repeated three times a
day for four days (days 1−4). The swimming pattern of the
mice was recorded by a camera placed above the center of the
pool, and the escape latency, escape distance, and swimming
speed of the mice were assessed by a ZS-001 video analysis
system (Beijing, China).
The probe test was performed 24 h (i.e., day 5) after the
navigation test for assessing memory consolidation. During the
experiment, the platform was removed from the pool, and the
mice were allowed to swim freely. The swimming pattern of
each mouse was monitored and recorded using a ZS-001
Figure 7. Potential mechanisms of curcumin involved in improving cognitive dysfunction in ApoE4-Tg mice. ApoE4 may trigger ER stress and then
activate the inflammatory signaling pathway to trigger neuroinflammation in the nervous system, leading to the occurrence of AD. However,
curcumin effectively inhibited the neuroinflammation caused by ApoE4 by inhibiting the occurrence of ER stress and inhibiting the activation of the
inflammatory signaling pathway and finally protected the learning and memory ability of ApoE4-Tg mice.
Figure 8. Overview of the protocol of the experimental procedures.
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system (Beijing, China) for 90 s. The time spent in the target
quadrant and the number of passes through the platform were
used to measure spatial memory.53
4.5. Collection and Preservation of Brain Tissues.
After the probe test, the mice were anesthetized and then
infused with phosphate-buffered saline (PBS). The brain was
immediately removed from the skull and divided into two
parts: one part was used for immunostaining and the other was
used for biochemical analysis. The brain tissues for
biochemical analysis were dissected on ice, and all brain
tissues were preserved at −80 °C for biochemical analysis.
4.6. Nissl Staining. The brain tissues were fixed in 4%
paraformaldehyde for 24 h and then dehydrated with an
alcohol gradient. Then, coronal sections (25 μm) were
obtained with a cryostat slicer and stained with cresyl violet
solution (0.1%) for 8 min. Next, the slices were dehydrated
with a series of ethanol solutions with increasing concentration
(50, 70, 90, and 100% ethanol) and soaked in a mixture of
complete alcohol and xylene (1:1) for 10 min. The sections
were cleaned in xylene for 5 min, observed under a
microscope, and photographed.
4.7. Immunofluorescence Staining. Sections were
sealed with 3% H2O2 and 0.3% Triton-X 100 in PBS at
room temperature for 1 h, and then antigen repair was
performed with citric acid buffer. Following overnight
incubation with primary antibodies at 4 °C and an Alexa
Fluor 488-conjugated goat anti-rabbit IgG secondary antibody
at room temperature for 2 h, the cell nuclei were stained with
DAPI for 10 min. The samples were then examined using a
fluorescence microscope (Nikon, Tokyo, Japan), and the area
of immune response was quantified by ImageJ2x (National
Institutes of Health, Bethesda, MD).
4.8. Immunohistochemistry. The 5 μm slices were sealed
with 5% bovine serum albumin (BSA) and 0.3% Triton-X 100
in PBS for 1 h at room temperature, and then antigen repair
was performed with citric acid buffer. Slices were incubated
with the primary antibodies overnight at 4 °C, and goat anti-
rabbit IgG secondary antibodies were added for 30 min. Then,
diaminobenzidine was used for imaging, and hematoxylin was
used for staining. The immunopositive cells were stained
brown.54 The positive expression of the specific protein was
photographed and recorded under an inverted microscope, and
the positive area rate was calculated by ImageJ2x.
4.9. ELISA Assay. The levels of TNF-α and IL-1β in the
brain tissues were measured using ELISA kits according to the
manufacturer’s instructions. Flash-frozen brains from treated
mice were homogenized and lysed to perform ELISA using the
tissue lysate. Absorbance values were determined by a
microplate reader, and sample concentration was analyzed
using the standard curves.
4.10. Western Blotting. Protein concentrations were
measured using a protein assay kit according to the
manufacturer’s instructions. The extracted proteins were
separated by SDS-polyacrylamide gel electrophoresis and
then transferred to a membrane for 30 min. The membrane
was blocked with 5% skim milk and then incubated at 4 °C
overnight with the following primary antibodies: GRP78,
IRE1α, p65, p-p65, β-actin, or lamin B. Then, the membrane
was washed three times with TBST and incubated with the
secondary antibody for 2 h. The ECL method was used to
develop the film, and dark room exposure analysis and
ImageJ2x analysis software were used to analyze the grayscale
values.55
4.11. Statistical Analysis. Data are presented as the mean
± SEM. Comparisons between groups were performed with
one-way ANOVA followed by Dunnett’s post hoc test. p < 0.05
was considered statistically significant.
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